GeneProof’s Merger with ALPC

Dentons has advised GeneProof founders Radek Horvath and Milos Dendis on the deal, while Glatzova & Co advised the Silicon Valley Bank.

GeneProof executed a merger with the American Laboratory Products Company, leading to the establishment of the ALPCO Group. 

GeneProof is a Czech molecular diagnostics company that provides customers with solutions in the field of molecular in vitro diagnostics of serious infections and genetic diseases.

The American Laboratory Products Company is a US specialty in vitro diagnostics company.

Silicon Valley Bank is a US-based high-tech commercial bank specializing in lending to technology companies and providing multiple services to venture capital, revenue-based financing, and private equity firms that invest in technology and biotechnology.

The Dentons Prague-based team included Partners Jan Prochazka (Picture) and Daniel Hurych, Senior Associates Vojtech Novak and Adam Prerovsky, Associates Ondrej Vales and Michal Pelikan, Junior Associate Blanka Crhakova, and Honorary Member Petr Kotab, with the help of New York-based Partner Ilan Katz.

The Glatzova & Co team included Partner Libor Nemec, Managing Associate Jarmila Tornova, and Junior Associate Tomas Farnik.

Involved fees earner: Blanka Crháková – Dentons; Daniel Hurych – Dentons; Ilan Katz – Dentons; Petr Kotáb – Dentons; Vojtech Novak – Dentons; Michal Pelikán – Dentons; Adam Prerovsky – Dentons; Jan Procházka – Dentons; Ond?ej Valeš – Dentons; Tomas Farnik – Glatzova & Co; Libor Nemec – Glatzova & Co; Jarmila Tornova – Glatzova & Co;

Law Firms: Dentons; Glatzova & Co;

Clients: Milos Dendis; Radek Horvath; Silicon Valley Banks;